Clinical Trial 42495

Upland, CA 91786


A randomized, double-blind, double-dummy, active controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of abbv-3373 in subjects with moderate to severe rheumatoid arthritis.

Qualified Participants Must:

• Attend all study visits
• Be diagnosed with rheumatoid arthritis
• Adult male or female
• Between 18 and 75 years of age inclusive at screening
• Be biologic naive
• Incomplete response to methotrexate of 15mg to 25mg and stable for 3 months prior to first dose

Qualified Participants May Receive:

Study treatment at no cost, doctors visit at no cost, blood work results at no cost, receive $40.00 per visit once patient has been qualified and enrolled into the study.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.